|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | |
| A61K 45/06 | |||
| A61K 48/00 | |||
| A61K 9/51 | |||
| A61K 31/58 |
| (11) | Number of the document | 3454835 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17721707.2 |
| Date of filing the European patent application | 2017-05-08 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/060891 |
| Date | 2017-05-08 |
| (87) | Number | WO 2017/194454 |
| Date | 2017-11-16 |
| (30) | Number | Date | Country code |
| 201662333574 P | 2016-05-09 | US | |
| 201662359429 P | 2016-07-07 | US | |
| 201762449623 P | 2017-01-24 | US |
| (72) |
LINDFORS, Lennart, SE
KJELLMAN, Tomas, SE
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (54) | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF |
| LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF |